On the metabolic side, osteosarcoma cells typically exhibit glycolysis-biased pyruvate metabolism through PKM2, LDHA, and lactate transporters, processes that not only support proliferation but also remodel the tumor microenvironment and impair immune function (7, 53). Here, PKM is linked to neoplasm.